Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 11,500.00
Ask: 12,270.00
Change: 0.00 (0.00%)
Spread: 770.00 (6.696%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Stocks dip on surging virus cases, stimulus doubts

Mon, 26th Oct 2020 13:22

* Unease over record virus cases in Europe, U.S.

* German DAX hits three-month low as SAP slumps

* Investors seek dollar safety

* Italy bond yields slide after S&P move

* Eyes this week on central bank meetings, U.S. GDP data

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

By Tom Arnold and Wayne Cole

LONDON/SYDNEY, Oct 26 (Reuters) - Global shares fell on
Monday as surging coronavirus cases in Europe and the United
States clouded the global economic outlook, while China's
leaders meet to plan the country's economic future.

The United States has seen its highest-ever number of new
COVID-19 cases in the past two days. France also set case
records and Spain announced a state of emergency.

The coronavirus resurgence, along with no clear progress on
a U.S. stimulus package and caution before the Nov. 3 U.S.
election, dragged the MSCI world equity index
down 0.3%. In Europe, the Euro STOXX 600 shed 1%. S&P
500 futures fell 1%.

"The decreasing likelihood of U.S. fiscal stimulus
pre-election, possibly even pre-year-end, as well as worsening
virus numbers and increasing lockdown measures, all seem to be
taking the shine off what was a rather complacent market view of
the outlook," said James Athey, investment director at Aberdeen
Standard Investments.

Europe became the second region after Latin America to
surpass 250,000 deaths on Saturday, according to a Reuters
tally, as many European countries reported their highest number
of COVID-19 cases in a single day.

Milan's blue-chip index sank 1% as new curbs on
public venues overshadowed Friday's news that ratings agency S&P
Global had upgraded the nation's sovereign outlook to stable
from negative.

The German DAX slumped 2.7% to a three-month low
after software company SAP abandoned medium-term
profitability targets and warned its business would take longer
than expected to recover from the pandemic.

Sentiment was also hit by a survey showing German business
morale fell for the first time in six months in October.

Reports of progress in a COVID-19 vaccine being developed by
the University of Oxford and manufactured by drug maker
AstraZeneca Plc helped limit some of the market
sell-off, analysts said.

MSCI's broadest index of Asia-Pacific shares outside Japan
shed 0.2%. Japan's Nikkei finished 1%
lower, and South Korea's main index lost 0.7%.

Chinese blue chips shed 0.6% as the country's
leaders met to chart the nation's economic course for 2021-2025,
balancing growth with reforms amid an uncertain global outlook
and worsening relations with the United States.

In a packed week for monetary policy decisions, Canada's and
Japan's central banks are expected to hold fire for now. Markets
assume the European Central Bank will sound cautious on
inflation and growth even if it skips a further easing.

Data due out Thursday is forecast to show a consumer-led
31.9% rebound in U.S. economic output in the third quarter,
after the second quarter's historic collapse.

Analysts at Westpac noted such a bounce would still leave
2020 GDP around 4% below last year's, with business investment
still lagging badly.

As markets increasingly price in the likelihood of a
Democratic president and Congress and resulting rise in
government spending and borrowing, U.S. 10-year Treasury yields
hit their highest since early June last week at 0.8720%
. They were trading at 0.81% on Monday.

"We have raised the probability of a Democratic sweep,
already our base case, from 40% to just over 50% and have
increased our expectation of Biden to win from 65% to 75%,"
NatWest Markets analysts said. "We see steeper U.S. yield curves
and a weaker USD as likely to prevail in our base case."

Italian government bond yields slid across the curve, with
short-dated yields falling to a one-year low, after S&P Global's
unexpected outlook upgrade.

The benchmark 10-year yield dropped 6 basis points to 0.70%
. Short-dated two-year Italian yields hit
their lowest level in a year at -0.382%.

Surging coronavirus cases sent investors to the safety of
the dollar after it fell broadly last week.

An index tracking its value against a basket of currencies
firmed 0.1% to 92.92, while euro/dollar - the most traded
currency pair and part of the index - fell 0.3% to 1.1826
.

In commodity markets, gold was 0.1% higher at
$1,902.06 per ounce.

Oil prices extended last week's losses as the prospect of
increased supply and resurgent coronavirus infections worried
investors.

Brent crude was down 1.9% at $40.97 a barrel. U.S.
West Texas Intermediate (WTI) dropped 2.1% to $39.03.

(Reporting by Tom Arnold in London and Wayne Cole in Sydney;
editing by Shri Navaratnam, Tomasz Janowski, Larry King)

More News
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.